ExpreS2ion Biotech Holding AB (EXPRS2) — Strategic Asset Allocation Index
ExpreS2ion Biotech Holding AB (EXPRS2) has a Strategic Asset Allocation Index of 1.3% as of December 2025. Strategic assets (PP&E of Skr465.00K plus long-term investments of Skr-) total Skr465.00K, measured against net assets of Skr35.69 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
ExpreS2ion Biotech Holding AB Strategic Asset Allocation Index (2016–2025)
This chart shows how ExpreS2ion Biotech Holding AB's Strategic Asset Allocation Index has evolved across 9 annual periods from 2016 to 2025. As of December 2025, the index stands at 1.3%, representing strategic assets of Skr465.00K against net assets of Skr35.69 Million SEK. Explore ExpreS2ion Biotech Holding AB (EXPRS2) cash flow conversion to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for ExpreS2ion Biotech Holding AB (2016–2025)
The table below presents the year-by-year Strategic Asset Allocation Index for ExpreS2ion Biotech Holding AB from 2016 to 2025, covering 9 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see how much is ExpreS2ion Biotech Holding AB worth.
| Year | SAAI | Strategic Assets (SEK) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1.3% | Skr465.00K | Skr465.00K | Skr- | Skr35.69 Million | ▼ -1.1 pp |
| 2024 | 2.4% | Skr1.53 Million | Skr1.53 Million | Skr- | Skr64.42 Million | ▼ -0.3 pp |
| 2023 | 2.7% | Skr1.77 Million | Skr1.77 Million | Skr- | Skr65.36 Million | ▲ +1.8 pp |
| 2022 | 0.9% | Skr910.00K | Skr910.00K | Skr- | Skr103.33 Million | ▲ +0.0 pp |
| 2021 | 0.9% | Skr1.21 Million | Skr1.21 Million | Skr- | Skr140.35 Million | ▼ -0.5 pp |
| 2020 | 1.4% | Skr1.29 Million | Skr1.29 Million | Skr- | Skr94.55 Million | ▼ -10.6 pp |
| 2018 | 12.0% | Skr993.00K | Skr993.00K | Skr- | Skr8.30 Million | ▲ +2.6 pp |
| 2017 | 9.4% | Skr632.00K | Skr632.00K | Skr- | Skr6.74 Million | ▲ +4.1 pp |
| 2016 | 5.3% | Skr679.00K | Skr679.00K | Skr- | Skr12.88 Million | — |